Full-Time

Associate Director

Biosample Operations

Posted on 10/24/2024

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops monoclonal antibodies for infectious diseases

AI & Machine Learning
Biotechnology

Compensation Overview

$168.5k - $246kAnnually

Senior

No H1B Sponsorship

San Francisco, CA, USA

Requires onsite presence in San Francisco for four days per week.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • Life Science Degree or Higher
  • At least 7+ years related professional experience in a clinical research setting, clinical/diagnostic laboratory, or pharmaceutical/biotechnology R&D environment
  • 3+ years Clinical or biological laboratory experience with involvement in the processing or analysis of biological samples
  • Clinical development experience working on a crossfunctional team responsible for the execution of clinical studies, oncology preferred
  • Competent in application of standard business procedures (standard operating procedures, International Conference on Harmonization {ICH}, Global Regulations, Ethics and Compliance)
  • Project management skills and knowledge of project management tools
Responsibilities
  • Drive the implementation and execution of the clinical biomarker and diagnostic plans for therapeutic programs in early and late stage clinical development across therapeutic areas
  • Accountable for project management and appropriate planning of related biomarker analysis and samples management costs within a project(s) or clinical studies
  • Plan and implement the PK and biomarker and diagnostics biosamples collection within a project(s) or clinical study including definition of the appropriate material, instructions, lab manual development Kit development, database set up, etc
  • Ensure the timely and efficient delivery of all biosample, including scheduling analyses with relevant vendors, sample processing and shipment, analysis, data delivery and final sample disposition.
  • Serve as vendor operations lead with central lab and other ancillary labs and will oversee sample shipment and coordination of sample analyses, data transfers and sample reconciliation
  • Be the first contact for PK biomarker and diagnostics biosamples operational questions and issues within a project(s) and coordinates with internal and external partners
  • Provide guidance during protocol, informed consent form and CRF development to ensure feasibility of biological sampling and alignment with ICH/GCP, sample testing plans and data collection and reconciliation
  • Develop and implement a global strategy for standardization of clinical sample management for inspection readiness including development of SOPs for practices across clinical programs
  • Accountable for training, managing, and providing oversight of Biomarker Operations team and driving the overall biomarker operational strategy for the pipeline

Vir Biotechnology develops treatments that leverage the immune system to combat infectious diseases. They use a proprietary platform for monoclonal antibodies and integrate machine learning to create a database of human antibodies, which helps in designing effective medicines. Their pipeline includes candidates for hepatitis B, HIV, and various viruses like influenza and COVID-19, setting them apart through collaborations with industry leaders. The company's goal is to transform lives by addressing unmet medical needs with innovative therapies.

Company Stage

IPO

Total Funding

$640.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

2%

1 year growth

5%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent bullish quarterly reports and increased analyst estimates suggest strong financial performance.
  • Significant investments, such as the $214,000 from Diversified Trust Co, indicate confidence in Vir's future prospects.
  • Presentations at high-profile conferences like J.P. Morgan's Annual Healthcare Conference and AASLD's The Liver Meeting® enhance Vir's visibility and credibility in the biotech community.

What critics are saying

  • Recent layoffs and facility shutdowns indicate potential financial instability and operational challenges.
  • The resignation of key executives, including the CFO and Chief Medical Officer, could lead to strategic and leadership uncertainties.

What makes Vir Biotechnology unique

  • Vir Biotechnology's focus on leveraging immunology expertise to engineer human antibodies into powerful medicines sets it apart from competitors.
  • Their rapid growth, as evidenced by being ranked the fastest-growing company in North America on the 2023 Deloitte Technology Fast 500, highlights their market impact.
  • Vir's ongoing Phase 2 trials for chronic hepatitis delta and B demonstrate their commitment to addressing unmet medical needs with innovative therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement

INACTIVE